Integra Ventures
15
20M
11
1
0.27
6
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Seattle.
The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Integra Ventures is 50-100 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2007. Comparing to the other companies, this Integra Ventures performs on 11 percentage points more the average number of lead investments. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. The increased amount of exits for fund were in 2014.
The current fund was established by Joseph Piper. The overall number of key employees were 3.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Integra Ventures, startups are often financed by Novo Holdings, JT International, JPMorgan Partners (JPMP). The meaningful sponsors for the fund in investment in the same round are Novo Holdings, Hambrecht & Quist Capital Management, Washington Research Foundation.. In the next rounds fund is usually obtained by Hambrecht & Quist Capital Management, Burrill & Company, WestRiver Group, LLC.
Among the most popular portfolio startups of the fund, we may highlight Raven Biotechnologies, Calypso Medical, Blue Heron Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical, Health Care.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 1
- Exits
- 6
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (12)
- Health Care (8)
- Medical (5)
- Therapeutics (4)
- Pharmaceutical (4) Show 14 more
- Investments by region
-
- United States (15)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 33M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.93
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tepha | 06 Jun 2007 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 10M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.